TY - JOUR
T1 - Solubility properties in biological media 9
T2 - Prediction of solubility and partition of organic nonelectrolytes in blood and tissues from solvatochromic parameters
AU - Kamlet, Mortimer J.
AU - Doherty, Ruth M.
AU - Fiserova‐Bergerova, Vera
AU - Carr, Peter W.
AU - Abraham, Michael H.
AU - Taft, Robert W.
PY - 1987/1
Y1 - 1987/1
N2 - Solubilities in and partition among human blood, brain, lung, kidney, muscle, and fat tissue are well correlated by linear solvation energy relationships of the form: XYZ = XYZo + mVI/100 + sπ* + bßm where XYZ is the logarithm of the solubility property, VI is the intrinsic (van der Waals') molar volume, π* and β are the solvatochromic parameters that measure solute dipolarity/polarizability and hydrogenbond acceptor basicity, respectively, and the subscript m indicates that for self‐associating compounds, the parameter applies to the non‐self‐associated “monomer” solute. The equation for log K(brain—blood) indicates that increasing molar volume favors, whereas increasing dipolarity and hydrogen‐bond acceptor basicity oppose, solute transfer from blood into brain.
AB - Solubilities in and partition among human blood, brain, lung, kidney, muscle, and fat tissue are well correlated by linear solvation energy relationships of the form: XYZ = XYZo + mVI/100 + sπ* + bßm where XYZ is the logarithm of the solubility property, VI is the intrinsic (van der Waals') molar volume, π* and β are the solvatochromic parameters that measure solute dipolarity/polarizability and hydrogenbond acceptor basicity, respectively, and the subscript m indicates that for self‐associating compounds, the parameter applies to the non‐self‐associated “monomer” solute. The equation for log K(brain—blood) indicates that increasing molar volume favors, whereas increasing dipolarity and hydrogen‐bond acceptor basicity oppose, solute transfer from blood into brain.
UR - http://www.scopus.com/inward/record.url?scp=0023144509&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023144509&partnerID=8YFLogxK
U2 - 10.1002/jps.2600760105
DO - 10.1002/jps.2600760105
M3 - Article
C2 - 3585716
AN - SCOPUS:0023144509
SN - 0022-3549
VL - 76
SP - 14
EP - 17
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
IS - 1
ER -